PARP1 and breast carcinoma: The ‘‘YB-1-PARP1’’ loop was proven to play a crucial role in the CDK4/6i resistance of breast cancer, and blocking the factor in the ‘‘YB-1-PARP1’’ loop can enhance the sensitivity of CDK4/6i efficiency.